mohit

Mohit Kaushal

Former Expert

Mohit Kaushal is a Visiting Scholar in Economic Studies at the Center for Health Care Policy, working with the Richard Merkin Initiative for Payment Reform and Clinical Leadership. Mohit has had an extensive career within investing, clinical medicine/academia and public policy.

Mohit is a lead investor, board member or advisor to numerous transformational companies including Humedica (acquired by Optum Health), Rxante (acquired by Millennium), Change Healthcare (acquired by Emdeon), Gravie, Elation Health and CitiusTech.

During his time in the Obama administration, he was a member of the White House Health IT task force; a cross agency team implementing the technology aspects of Health Reform. He also built and led the first dedicated health care team at the Federal Communications Commission, where his team initiated collaboration with the Food and Drug Administration for the regulatory streamlining of converged telecommunications, data analytics and medical devices leading to the release of the mobile medical applications guidance by the FDA.

In addition Dr. Kaushal is an Adjunct Professor at Stanford University with a joint position within the newly created Biomedical Data Science Department and the medical school.

Dr. Kaushal continues to be active within public policy and is a Visiting Scholar at the Brookings Institution and has been appointed to the FDASIA Workgroup of the Health IT Policy Committee and to the National Committee on Vital and Health Statistics, advising HHS on Data Access and Use.

Kaushal is an ER physician, holds an MBA from Stanford and an MD with distinction from Imperial College of Science, Technology and Medicine, London.

Mohit Kaushal is a Visiting Scholar in Economic Studies at the Center for Health Care Policy, working with the Richard Merkin Initiative for Payment Reform and Clinical Leadership. Mohit has had an extensive career within investing, clinical medicine/academia and public policy.

Mohit is a lead investor, board member or advisor to numerous transformational companies including Humedica (acquired by Optum Health), Rxante (acquired by Millennium), Change Healthcare (acquired by Emdeon), Gravie, Elation Health and CitiusTech.

During his time in the Obama administration, he was a member of the White House Health IT task force; a cross agency team implementing the technology aspects of Health Reform. He also built and led the first dedicated health care team at the Federal Communications Commission, where his team initiated collaboration with the Food and Drug Administration for the regulatory streamlining of converged telecommunications, data analytics and medical devices leading to the release of the mobile medical applications guidance by the FDA.

In addition Dr. Kaushal is an Adjunct Professor at Stanford University with a joint position within the newly created Biomedical Data Science Department and the medical school.

Dr. Kaushal continues to be active within public policy and is a Visiting Scholar at the Brookings Institution and has been appointed to the FDASIA Workgroup of the Health IT Policy Committee and to the National Committee on Vital and Health Statistics, advising HHS on Data Access and Use.

Kaushal is an ER physician, holds an MBA from Stanford and an MD with distinction from Imperial College of Science, Technology and Medicine, London.

Get daily updates from Brookings